Status:

COMPLETED

Clinical Validation Study for iVue

Lead Sponsor:

Optovue

Conditions:

Normal and Ocular Pathology

Eligibility:

All Genders

18-80 years

Brief Summary

To demonstrate clinical substantial equivalence of iVue as comparable to commercially available RTVue.

Eligibility Criteria

Inclusion

  • Inclusion Criteria:
  • Normal: Normal results from clinical exam and free of ocular pathology.
  • Glaucoma: Clinical exam results consistent with glaucoma and visual field defects consistent with glaucoma.
  • Cornea: Clinical exam results consistent with cornea pathology.
  • Retina: Clinical exam results consistent with retina pathology

Exclusion

    Key Trial Info

    Start Date :

    October 1 2009

    Trial Type :

    OBSERVATIONAL

    Allocation :

    ACTUAL

    End Date :

    September 1 2010

    Estimated Enrollment :

    48 Patients enrolled

    Trial Details

    Trial ID

    NCT01242553

    Start Date

    October 1 2009

    End Date

    September 1 2010

    Last Update

    September 28 2017

    Active Locations (2)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (2 locations)

    1

    Pacific Eye Specialists

    Daly City, California, United States, 94015

    2

    Colorado Retina Center

    Denver, Colorado, United States, 80204